The Aquafresh and Panadol drugs business GSK has sold two of its travel vaccines for up to €955 million, the company has announced.

Two new ebola vaccine trials began with volunteers in Britain, France and Senegal getting “prime-boost” immunisations developed by Bavarian Nordic, GlaxoSmithKline and Johnson & Johnson.